Skip to main content

Table 2 EUS, MRI and post-operative pathological TN staging of the studied patients

From: Endoluminal ultrasound versus magnetic resonance imaging in assessment of rectal cancer after neoadjuvant therapy

 

EUS

MRI

Pathology

Early

T0

6.8% (5)

T1

13.7% (10)

2.7% (2)

12.3% (9)

T2

19.2% (14)

28.8% (21)

21.9% (16)

Late

T3

47.9% (35)

45.2% (33)

49.3% (36)

T4

19.2% (14)

16.4% (12)

16.4% (12)

Node

N0

52.1% (38)

50.7% (37)

54.8% (40)

N1

38.4% (28)

43.8% (32)

30.1% (22)

N2

9.6% (7)

5.5% (4)

15.1% (11)

Sphincter

Free

93.2% (68)

93.2% (68)

Infiltrated

6.8% (5)

6.8% (5)

  1. Data is expressed percentage and frequency